Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses <i>In Vitro</i>
New therapeutics are urgently needed in the fight against COVID-19. Repurposing drugs that are either already approved for human use or are in advanced stages of the approval process can facilitate more rapid advances toward this goal.
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
American Society for Microbiology
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/620d821873f544a29175de77273152c9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:620d821873f544a29175de77273152c9 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:620d821873f544a29175de77273152c92021-11-03T18:15:37Z Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses <i>In Vitro</i> 2161-21292150-751110.1128/mBio.03495-20https://doaj.org/article/620d821873f544a29175de77273152c92021-02-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.03495-20https://doaj.org/toc/2161-2129https://doaj.org/toc/2150-7511 New therapeutics are urgently needed in the fight against COVID-19. Repurposing drugs that are either already approved for human use or are in advanced stages of the approval process can facilitate more rapid advances toward this goal.Nathan E. StoneSierra A. JaramilloAshley N. JonesAdam J. VazquezMadison MartzLora M. VersluisMarlee O. RaniereHaley E. NunnallyKatherine E. ZarnRoxanne NottinghamKen R. NgJason W. SahlDavid M. WagnerSteen KnudsenErik W. SettlesPaul KeimChristopher T. FrenchAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 1 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Microbiology QR1-502 |
| spellingShingle |
Microbiology QR1-502 Nathan E. Stone Sierra A. Jaramillo Ashley N. Jones Adam J. Vazquez Madison Martz Lora M. Versluis Marlee O. Raniere Haley E. Nunnally Katherine E. Zarn Roxanne Nottingham Ken R. Ng Jason W. Sahl David M. Wagner Steen Knudsen Erik W. Settles Paul Keim Christopher T. French Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses <i>In Vitro</i> |
| description |
New therapeutics are urgently needed in the fight against COVID-19. Repurposing drugs that are either already approved for human use or are in advanced stages of the approval process can facilitate more rapid advances toward this goal. |
| format |
article |
| author |
Nathan E. Stone Sierra A. Jaramillo Ashley N. Jones Adam J. Vazquez Madison Martz Lora M. Versluis Marlee O. Raniere Haley E. Nunnally Katherine E. Zarn Roxanne Nottingham Ken R. Ng Jason W. Sahl David M. Wagner Steen Knudsen Erik W. Settles Paul Keim Christopher T. French |
| author_facet |
Nathan E. Stone Sierra A. Jaramillo Ashley N. Jones Adam J. Vazquez Madison Martz Lora M. Versluis Marlee O. Raniere Haley E. Nunnally Katherine E. Zarn Roxanne Nottingham Ken R. Ng Jason W. Sahl David M. Wagner Steen Knudsen Erik W. Settles Paul Keim Christopher T. French |
| author_sort |
Nathan E. Stone |
| title |
Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses
<i>In Vitro</i>
|
| title_short |
Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses
<i>In Vitro</i>
|
| title_full |
Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses
<i>In Vitro</i>
|
| title_fullStr |
Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses
<i>In Vitro</i>
|
| title_full_unstemmed |
Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses
<i>In Vitro</i>
|
| title_sort |
stenoparib, an inhibitor of cellular poly(adp-ribose) polymerase, blocks replication of the sars-cov-2 and hcov-nl63 human coronaviruses
<i>in vitro</i> |
| publisher |
American Society for Microbiology |
| publishDate |
2021 |
| url |
https://doaj.org/article/620d821873f544a29175de77273152c9 |
| work_keys_str_mv |
AT nathanestone stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT sierraajaramillo stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT ashleynjones stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT adamjvazquez stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT madisonmartz stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT loramversluis stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT marleeoraniere stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT haleyenunnally stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT katherineezarn stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT roxannenottingham stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT kenrng stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT jasonwsahl stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT davidmwagner stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT steenknudsen stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT erikwsettles stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT paulkeim stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi AT christophertfrench stenoparibaninhibitorofcellularpolyadpribosepolymeraseblocksreplicationofthesarscov2andhcovnl63humancoronavirusesiinvitroi |
| _version_ |
1718445459977011200 |